Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
2 other identifiers
observational
400
1 country
1
Brief Summary
Strabismus (misalignment of the eyes) often runs in families. In this study, the investigators are looking for genetic variants associated with strabismus and nystagmus. Three types of subects will be enrolled: (1) Families with at least 3 members with strabismus, (2) individuals with infantile esotropia and their parents and siblings, and (3) individuals with infantile nystagmus and their parents. Whole exome and/or whole genome sequencing will be used to identify genetic variants shared by family members with strabismus and to identify genetic causes of nystagmus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2021
CompletedFirst Posted
Study publicly available on registry
February 25, 2021
CompletedStudy Start
First participant enrolled
September 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
December 12, 2025
December 1, 2025
9.2 years
February 23, 2021
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Genetic variants
genetic variants shared by family members with strabismus
2 years
Interventions
Whole genome sequencing or whole exome sequencing will be performed for all enrolled participants.
Eligibility Criteria
All willing members of families in which 3 or more biological relatives have strabismus (esotropia, exotropia, or vertical misalignments) with full eye movements, or affected individual has infantile esotropia or infantile nystagmus.
You may qualify if:
- \- Member of a family with at least 3 biological relatives with strabismus. (Both affected and non-affected family members will be enrolled).
- \- Member of a family with at least 1 individual with infantile esotropia. (Both affected and non-affected family members will be enrolled).
- \- Member of a family with at least 1 individual with infantile nystagmus. (Both affected and non-affected family members will be enrolled).
You may not qualify if:
- paralytic strabismus in affected family members
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- National Eye Institute (NEI)collaborator
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Biospecimen
DNA
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Whitman, MD/PhD
Assistant Professor
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Ophthalmology
Study Record Dates
First Submitted
February 23, 2021
First Posted
February 25, 2021
Study Start
September 3, 2021
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
December 12, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- At time of publication
- Access Criteria
- de-identified data will be available per dbGAP access policies.
De-identified genetic data will be deposited in dbGAP (database of genotypes and phenotypes) after publication.